Ascendis Pharma A (ASND) Equity Ratio (2016 - 2025)
Ascendis Pharma A (ASND) has disclosed Equity Ratio for 10 consecutive years, with 0.12 as the latest value for Q4 2025.
- Quarterly Equity Ratio fell 39.48% to 0.12 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.12 through Dec 2025, down 39.48% year-over-year, with the annual reading at 0.12 for FY2025, 39.48% down from the prior year.
- Equity Ratio hit 0.12 in Q4 2025 for Ascendis Pharma A, down from 0.09 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.81 in Q4 2021 to a low of 0.18 in Q4 2023.
- Historically, Equity Ratio has averaged 0.13 across 5 years, with a median of 0.09 in 2024.
- Biggest five-year swings in Equity Ratio: plummeted 173.03% in 2023 and later surged 49.22% in 2024.
- Year by year, Equity Ratio stood at 0.81 in 2021, then tumbled by 70.33% to 0.24 in 2022, then tumbled by 173.03% to 0.18 in 2023, then surged by 49.22% to 0.09 in 2024, then crashed by 39.48% to 0.12 in 2025.
- Business Quant data shows Equity Ratio for ASND at 0.12 in Q4 2025, 0.09 in Q4 2024, and 0.18 in Q4 2023.